Paper32259264
Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer.
Yu Y and 9 others. JAMA Netw Open, 2020. Cited by 83 papers, by iCite.
Cite this record
ConductScience Library. Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer. Papers, record 32259264. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32259264
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunotherapy | Major topic |
| Neoplasms | Major topic |
| RNA, Long Noncoding | Major topic |
| Adult | |
| Aged | |
| Algorithms | |
| B7-H1 Antigen | |
| Biomarkers | |
| Case-Control Studies | |
| China | |
| Cohort Studies | |
| Disease-Free Survival | |
| Female | |
| Humans | |
| Male | |
| Melanoma | |
| Middle Aged | |
| T-Lymphocytes, Cytotoxic | |
| Tumor Burden | |
| Urinary Bladder Neoplasms |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29443960 | TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. | Nature | 2018 | https://conductscience.org/library/papers/29443960 | PubMed |
| 2 | 30936474 | Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. | Nat Cell Biol | 2019 | https://conductscience.org/library/papers/30936474 | PubMed |
| 3 | 25569120 | Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. | BMJ | 2015 | https://conductscience.org/library/papers/25569120 | PubMed |
| 4 | 30127393 | Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. | Nat Med | 2018 | https://conductscience.org/library/papers/30127393 | PubMed |
| 5 | 31290993 | Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis. | JAMA Netw Open | 2019 | https://conductscience.org/library/papers/31290993 | PubMed |
| 6 | 31436822 | Multiomics Prediction of Response Rates to Therapies to Inhibit Programmed Cell Death 1 and Programmed Cell Death 1 Ligand 1. | JAMA Oncol | 2019 | https://conductscience.org/library/papers/31436822 | PubMed |
| 7 | 24071849 | The Cancer Genome Atlas Pan-Cancer analysis project. | Nat Genet | 2013 | https://conductscience.org/library/papers/24071849 | PubMed |
| 8 | 29541787 | Quantifying tumor-infiltrating immune cells from transcriptomics data. | Cancer Immunol Immunother | 2018 | https://conductscience.org/library/papers/29541787 | PubMed |
| 9 | 29395328 | CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness. | Cell | 2018 | https://conductscience.org/library/papers/29395328 | PubMed |
| 10 | 30224822 | NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death. | Nat Immunol | 2018 | https://conductscience.org/library/papers/30224822 | PubMed |
| 11 | 24138885 | Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. | Immunity | 2013 | https://conductscience.org/library/papers/24138885 | PubMed |
| 12 | 25759022 | A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis. | Cancer Cell | 2015 | https://conductscience.org/library/papers/25759022 | PubMed |
| 13 | 10877287 | Time-dependent ROC curves for censored survival data and a diagnostic marker. | Biometrics | 2000 | https://conductscience.org/library/papers/10877287 | PubMed |
Cited by75
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42500647 | Long non-coding RNAs and their potential role in predicting immunotherapy response and prognosis: a systematic review. | Front Immunol | 2026 | https://conductscience.org/library/papers/42500647 | PubMed |
| 41454405 | Long non-coding RNAs in the tumor immune microenvironment of non-small cell lung cancer: mechanisms and clinical translational perspectives. | J Transl Med | 2025 | https://conductscience.org/library/papers/41454405 | PubMed |
| 40490527 | Tumor-associated macrophages-induced lncRNA RP11-627G18.1 promotes breast cancer metastasis. | Genes Immun | 2025 | https://conductscience.org/library/papers/40490527 | PubMed |
| 40342408 | Combinational therapeutic strategies to overcome resistance to immune checkpoint inhibitors. | Front Immunol | 2025 | https://conductscience.org/library/papers/40342408 | PubMed |
| 40282449 | Novel Biological Strategies for Melanoma Therapy: A Focus on lncRNAs and Their Targeting. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40282449 | PubMed |
| 39968500 | Phase I clinical trial to assess safety and efficacy of Oraxol, a novel oral paclitaxel chemotherapy agent, in patients with previously treated metastatic breast cancer. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/39968500 | PubMed |
| 39917986 | Unleashing the power of urine‑based biomarkers in diagnosis, prognosis and monitoring of bladder cancer (Review). | Int J Oncol | 2025 | https://conductscience.org/library/papers/39917986 | PubMed |
| 39812052 | Using Multi-Omics Methods to Understand Gouty Arthritis. | Curr Rheumatol Rev | 2026 | https://conductscience.org/library/papers/39812052 | PubMed |
| 39725831 | Pan-cancer and multiomics: advanced strategies for diagnosis, prognosis, and therapy in the complex genetic and molecular universe of cancer. | Clin Transl Oncol | 2025 | https://conductscience.org/library/papers/39725831 | PubMed |
| 39712455 | Combined pyrotinib and fulvestrant for hormone receptor-positive and HER2-positive metastatic breast cancer: A multicenter, single-arm, phase II trial. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/39712455 | PubMed |
| 39669975 | Multimodal data fusion AI model uncovers tumor microenvironment immunotyping heterogeneity and enhanced risk stratification of breast cancer. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/39669975 | PubMed |
| 39633711 | Noncoding RNA, friend or foe for nephrolithiasis? | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39633711 | PubMed |
| 39242755 | LncRNA sequencing reveals an essential role for the lncRNA-mediated ceRNA network in penile squamous cell carcinoma. | Genes Immun | 2024 | https://conductscience.org/library/papers/39242755 | PubMed |
| 39000359 | Genomic and Epigenomic Biomarkers of Immune Checkpoint Immunotherapy Response in Melanoma: Current and Future Perspectives. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39000359 | PubMed |
| 38756447 | Deciphering the role of apoptosis signature on the immune dynamics and therapeutic prognosis in breast cancer: Implication for immunotherapy. | Front Genet | 2024 | https://conductscience.org/library/papers/38756447 | PubMed |
| 38720108 | Pan-cancer analysis for the prognostic and immunological role of CD47: interact with TNFRSF9 inducing CD8 + T cell exhaustion. | Discov Oncol | 2024 | https://conductscience.org/library/papers/38720108 | PubMed |
| 38546403 | The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/38546403 | PubMed |
| 38495207 | Synergistic role of activated CD4+ memory T cells and CXCL13 in augmenting cancer immunotherapy efficacy. | Heliyon | 2024 | https://conductscience.org/library/papers/38495207 | PubMed |
| 38434763 | Unraveling the role of M1 macrophage and CXCL9 in predicting immune checkpoint inhibitor efficacy through multicohort analysis and single-cell RNA sequencing. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/38434763 | PubMed |
| 38372785 | Current look at the most promising proteomic and glycomic biomarkers of bladder cancer. | J Cancer Res Clin Oncol | 2024 | https://conductscience.org/library/papers/38372785 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| CTLA4 | 1493 | PubTator's text mining | https://conductscience.org/library/genes/1493 | NCBI Gene |
| HIF1A | 3091 | PubTator's text mining | https://conductscience.org/library/genes/3091 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| NKILA | 105416157 | PubTator's text mining | https://conductscience.org/library/genes/105416157 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
| TMEM147 | 10430 | PubTator's text mining | https://conductscience.org/library/genes/10430 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32259264
GET https://conductscience.org/api/papers/v1/32259264/cited_by?page=2